Instrument Inactif

Autres langues Aastrom Biosciences Inc Nasdaq

Actions

US00253U3059

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

08/05	Vericel réduit sa perte au 1er trimestre, augmente son chiffre d'affaires et revoit à la hausse ses perspectives pour 2024 -- Les actions montent avant la cloche	MT
08/05	Transcript : Vericel Corporation, Q1 2024 Earnings Call, May 08, 2024

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Vericel Q1 Loss Narrows, Revenue Increases; 2024 Outlook Lifted -- Shares Rise Pre-Bell	08/05
Earnings Flash (VCEL) VERICEL CORPORATION Posts Q1 Revenue $51.3M, vs. Street Est of $49.1M	08/05
Vericel Reports First Quarter 2024 Financial Results and Raises Full-Year 2024 Financial Guidance	08/05
Vericel Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	08/05
Vericel Corporation Provides Earnings Guidance for the Year 2024	08/05
Vericel to Report First-Quarter 2024 Financial Results on May 8, 2024	24/04
Vericel Insider Sold Shares Worth $1,593,550, According to a Recent SEC Filing	19/04
Vericel Insider Sold Shares Worth $1,552,075, According to a Recent SEC Filing	15/03
Vericel Insider Sold Shares Worth $352,047, According to a Recent SEC Filing	13/03
Vericel Insider Sold Shares Worth $367,853, According to a Recent SEC Filing	11/03
Vericel Q4 EPS, Revenue Increase; Issues 2024 Outlook -- Shares Rise Pre-Bell	29/02
Vericel Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	29/02
Vericel Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29/02
Vericel Corporation Provides Earnings Guidance for the Fiscal Year 2024	29/02
Earnings Flash (VCEL) VERICEL CORPORATION Reports Q4 Revenue $65M, vs. Street Est of $64M	29/02
Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance	29/02
Vericel Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Full-Year 2024 Financial Guidance	29/02
North American Morning Briefing : Fed's Preferred -2-	29/02
Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024	27/02
Vericel to Present at the TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024	27/02

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Aastrom Biosciences Inc Nasdaq

Actions

US00253U3059

Autres langues

Filtres